Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Patients With Overactive Bladder Syndrome”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Testing effectiveness (Phase 2)Study completedNCT02790307
What this trial is testing

Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome

Who this might be right for
Overactive BladderMultiple Sclerosis
University College, London 48
Not applicableStudy completedNCT00775281
What this trial is testing

Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.

Who this might be right for
Overactive BladderPainful Bladder SyndromeChronic Pelvic Pain Syndrome+1 more
Insel Gruppe AG, University Hospital Bern 45
Post-approval studies (Phase 4)UnknownNCT03251300
What this trial is testing

Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing

Who this might be right for
Overactive Bladder Syndrome
Far Eastern Memorial Hospital 120
Post-approval studies (Phase 4)UnknownNCT05946902
What this trial is testing

Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study

Who this might be right for
Female Patients With Overactive Bladder Syndrome
Far Eastern Memorial Hospital 150
Post-approval studies (Phase 4)Study completedNCT01314781
What this trial is testing

Therapy of the Overactive Bladder Syndrome

Who this might be right for
Overactive Bladder
Cantonal Hospital, Frauenfeld 66
Not applicableUnknownNCT04693897
What this trial is testing

Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker

Who this might be right for
Overactive Bladder SyndromeDetrusor Overactivity
Chang Gung Memorial Hospital 400
Testing effectiveness (Phase 2)Study completedNCT01167257
What this trial is testing

Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome

Who this might be right for
Overactive Bladder
Buddhist Tzu Chi General Hospital 62
Early research (Phase 1)UnknownNCT05094414
What this trial is testing

Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS

Who this might be right for
Pain, ChronicUrge IncontinenceOveractive Bladder Syndrome+1 more
Buddhist Tzu Chi General Hospital 30
Large-scale testing (Phase 3)Study completedNCT03059134
What this trial is testing

Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

Who this might be right for
Urinary IncontinenceOveractive Bladder Syndrome
Buddhist Tzu Chi General Hospital 168
Not applicableStudy completedNCT01884753
What this trial is testing

Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.

Who this might be right for
Lower Urinary Tract DysfunctionOveractive Bladder Syndrome
Far Eastern Memorial Hospital 279
Not applicableStudy completedNCT01559623
What this trial is testing

Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms

Who this might be right for
Overactive Bladder Syndrome
University of Zurich 766
Not applicableStudy completedNCT01819168
What this trial is testing

Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

Who this might be right for
Overactive Bladder Syndrome
Far Eastern Memorial Hospital 38
Not applicableStudy completedNCT06143397
What this trial is testing

Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.

Who this might be right for
Multiple SclerosisOveractive Bladder Syndrome
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization 42
Post-approval studies (Phase 4)Study completedNCT06616675
What this trial is testing

Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

Who this might be right for
HTLV-1Overactive Bladder Syndrome
Hospital Universitário Professor Edgard Santos 42
Not applicableStudy completedNCT01282840
What this trial is testing

Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.

Who this might be right for
Lower Urinary Tract Symptoms
Far Eastern Memorial Hospital 676
Large-scale testing (Phase 3)UnknownNCT03758235
What this trial is testing

Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin

Who this might be right for
Overactive Bladder Syndrome
University Of Perugia 140
Post-approval studies (Phase 4)Study completedNCT00798434
What this trial is testing

Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

Who this might be right for
Urinary Bladder, Overactive
Pfizer 794
Not applicableEnded earlyNCT03080389
What this trial is testing

Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections

Who this might be right for
Overactive BladderOveractive DetrusorUrgency-Frequency Syndrome+1 more
The Cleveland Clinic 16
Large-scale testing (Phase 3)Study completedNCT00171145
What this trial is testing

A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.

Who this might be right for
Overactive Bladder Syndrome
Novartis 445
Not applicableUnknownNCT03435991
What this trial is testing

Experience Sampling Method in OAB Patients

Who this might be right for
Overactive BladderOveractive Bladder Syndrome
Maastricht University Medical Center 132
Load More Results